The financials
LeMaitre Vascular, Inc. by the numbers
LeMaitre Vascular, Inc. (LMAT) reported revenue of $67M in Q1 2026 (quarter ended March 31, 2026), up 11% from the same quarter a year earlier. That came with a gross margin of 73% and net income of $16M (24% of revenue). For the full year FY2025, revenue was $250M (+14% year on year) and net income $58M. Its largest region in 2026-Q1 was US at $37M, 56% of the disclosed total, just ahead of Other Countries at 25%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $67M | $60M | +11% |
| Gross profit | $48M | $41M | +17% |
| Operating income | $18M | $13M | +41% |
| Net income | $16M | $11M | +42% |
| Diluted EPS | $0.68 | $0.48 | +42% |
| Geographic | Revenue | Share |
|---|---|---|
| US | $37M | 56% |
| Other Countries | $17M | 25% |
| DE | $5.5M | 8.3% |
| CA | $4.1M | 6.1% |
| GB | $3.1M | 4.7% |
Business Segments
Revenue split by geographic segment, from SEC XBRL filings.
Latest period: Q1 2026Total $66.6M (+9.0%)
DE grew +39% year on yearGB -0.73% year on year
Segment Latestquarter on quarteryear on year
- US$37.2M$37.2MQoQ +7.5%year on year +7.4%+7.5%+7.4%
- Other Countries$16.6M$16.6MQoQ +12%year on year +16%+12%+16%
- DE$5.5M$5.5MQoQ +24%year on year +39%+24%+39%
- CA$4.1M$4.1MQoQ +5.8%year on year +8.9%+5.8%+8.9%
- GB$3.1M$3.1MQoQ -6.3%year on year -0.73%-6.3%-0.73%
Medical Instruments & Supplies
Ranks #9 of 27 by Smart Score